The key molecular sequence is APC/C activation after spindle assembly checkpoint satisfaction, followed by securin degradation. Because securin restrains separase, its removal releases separase to cleave cohesin, the protein complex maintaining sister-chromatid attachment. This ordered chain links checkpoint completion to physical chromatid separation, reducing the risk that genetic material is distributed inaccurately.
Checkpoint satisfaction serves as the permission point for the switch. The described mechanism places APC/C-dependent securin destruction after that checkpoint, rather than before it. This ordering matters because chromosome alignment must precede sister-chromatid separation. It therefore couples checkpoint surveillance with the decision to release separase and initiate the next stage of mitosis.
Separase release is not the only change at this switch. The transition also promotes changes in spindle forces and chromosome movement toward opposite poles. Thus, the process couples removal of the cohesin-mediated linkage with coordinated mechanical repositioning. Considering these events together helps explain why chromosome separation is a physical and regulatory process, not merely a timing change.
Researchers can follow the sequence of checkpoint satisfaction, APC/C targeting of securin, separase release, cohesin cleavage, and chromosome movement. Examining these events in order distinguishes a failure to authorize anaphase from a defect in cohesin removal or spindle behavior. This sequence provides a framework for interpreting where chromosome segregation becomes disrupted.
Tracking cohesin cleavage helps connect molecular control to chromosome stability. If cohesin is not removed appropriately, sister chromatids may fail to separate in the coordinated manner expected after checkpoint satisfaction. Studying this step can therefore identify how errors in the transition contribute to inaccurate genetic inheritance and, ultimately, aneuploidy.
Errors in checkpoint control or cohesin removal can generate aneuploidy, meaning an abnormal chromosome complement. The overview identifies aneuploidy as a feature associated with developmental disorders and cancer, so this transition provides a biological context for investigating how chromosome-segregation failures contribute to development and disease.